Position in MCRB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$78
-$10 QoQ
Shares Held
10
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MCRB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. MCRB ranks #390 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in MCRB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78 | 10 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $88 | 10 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,868 | 260 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $192 | 10 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $111 | 10 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,460 | 7,800 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $166 | 200 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $189 | 200 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $144 | 200 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $24,298 | 31,394 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $39,188 | 27,992 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $460,015 | 193,284 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $822,960 | 171,808 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $311,413 | 54,923 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,067 | 1,262 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $26,796 | 4,174 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,236 | 3,276 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $69,034 | 9,696 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $275,196 | 33,037 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $383,905 | 55,159 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $693,102 | 29,061 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,250,593 | 60,738 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,904,915 | 118,568 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,838,211 | 135,578 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $458,282 | 96,278 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $292,153 | 81,836 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||